骨折风险的自我认知:能告诉我们什么?
本研究基于GLOW国际队列中39,241名至少随访1年的≥55岁女性,分析自我感知骨折风险(SPR)与FRAX评估风险对骨折发生及抗骨质疏松药物(AOM)使用的关系。结果显示,5年随访期间2,132名(5.4%)发生主要骨质疏松性骨折;在每一SPR类别内,骨折风险随FRAX风险分级升高而增加;基线SPR较低者仅11%使用AOM,而SPR较高者为46%。作者认为SPR捕捉了常规预测工具未测量的骨折风险方面,并与改善的药物使用相关。
要点
- 在每一自我感知骨折风险类别内,骨折风险随FRAX风险分级升高而增加。
- 基线自我感知骨折风险较低的女性中仅11%使用抗骨质疏松药物,较高者为46%。
- 自我感知骨折风险较低但发生骨折的女性,其抗骨质疏松药物使用率仍低于自我感知风险较高者(无论是否骨折)。
核心结论
- 自我感知骨折风险捕捉了常规骨折预测工具目前未测量到的某些骨折风险方面,并与改善的药物使用相关。
- 充分认识骨折风险可能有益,并带来更多的医疗参与和治疗。
研究设计与样本
- GLOW为国际队列研究,涉及欧洲、北美和澳大利亚10个国家的723个医生诊所。
- 60,393名年龄≥55岁女性完成基线问卷,详细记录病史,包括共病、骨折和自我感知骨折风险(SPR)。
- 年度随访包括自我报告的 incident 骨折和抗骨质疏松药物(AOM)使用。
- 计算未包含骨密度测量的FRAX风险。
- 分析纳入至少1年随访数据的39,241名女性。
主要发现
- 在至少1年随访数据的39,241名女性中,2,132名(5.4%)在5年随访期间发生主要骨质疏松性骨折。
- 在每一SPR类别内,骨折风险随FRAX风险分级升高而增加。
- 基线SPR较低的女性中,仅11%在基线时使用AOM,而SPR较高的女性中为46%。
- 报告骨折后的数年中,AOM使用趋于增加。
- SPR较低但发生骨折的女性,其AOM使用率仍低于SPR较高但无骨折或有骨折的女性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: In this study, we report that self-perception of fracture risk captures some aspect of fracture risk not currently measured using conventional fracture prediction tools and is associated with improved medication uptake. It suggests that adequate appreciation of fracture risk may be beneficial and lead to greater healthcare engagement and treatment. INTRODUCTION: This study aimed to assess how well self-perception of fracture risk, and fracture risk as estimated by the fracture prediction tool FRAX, related to fracture incidence and uptake and persistence of anti-osteoporosis medication among women participating in the Global Longitudinal study of Osteoporosis in Women (GLOW). METHODS: GLOW is an international cohort study involving 723 physician practices across 10 countries in Europe, North America and Australia. Aged ≥ 55 years, 60,393 women completed baseline questionnaires detailing medical history, including co-morbidities, fractures and self-perceived fracture risk (SPR). Annual follow-up included self-reported incident fractures and anti-osteoporosis medication (AOM) use. We calculated FRAX risk without bone mineral density measurement. RESULTS: Of the 39,241 women with at least 1 year of follow-up data, 2132 (5.4%) sustained an incident major osteoporotic fracture over 5 years of follow-up. Within each SPR category, risk of fracture increased as the FRAX categorisation of risk increased. In GLOW, only 11% of women with a lower baseline SPR were taking AOM at baseline, compared with 46% of women with a higher SPR. AOM use tended to increase in the years after a reported fracture. However, women with a lower SPR who were fractured still reported lower AOM rates than women with or without a fracture but had a higher SPR. CONCLUSIONS: These results suggest that SPR captures some aspect of fracture risk not currently measured using conventional fracture prediction tools and is also associated with improved medication uptake.
引用
- Litwic AE, Compston JE, Wyman A, et al. Self-perception of fracture risk: what can it tell us? Osteoporos Int. 2017. PMID: 28861636. doi:10.1007/s00198-017-4200-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。